Many thanks to our sponsors for supporting this event. Please scroll down to read more about our supporters.

Gold Partner

abbvie Arlenda ClinStat Roche SAS

Silver Partner

ACI Clinical Merck Metronomia Novartis

Furthermore, we thank the following companies for their support:


Company Profiles

Gold Partner

ACI Clinical

Arlenda is offering services in statistics to the healthcare industry all along the product life cycle, from Research to Supply, including CMC and clinical development. Arlenda develops innovative statistical solutions to improve your decision-making processes, in particular to reduce the risk, to accelerate the development and to optimize processes. Arlenda offers also a series of 21 CFR Part 11 software to address method validation and product stability.
You are not convinced yet that statistics will improve your business, just contact us now at


ClinStat is an independent contract research organization located in Cologne as headquarter and Berlin, Germany. We offer services especially for pharmaceutical companies, medical device manufacturers, clinics and health companies. We support our customers in planning, conducting, reporting, and publication of their results of clinical trials, non-interventional trials, registries or desk research. Key aspects of our working practice are Clinical trials phase I to IV, Post-marketing studies, Health services research/Public health, Health economics/Modeling and Meta-analyses/Indirect comparisons. Our target is being your supporting agency in a persistent partnership.


Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide. In 2016, Roche invested CHF 9.9 billion in R&D and posted sales of CHF 50.6 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.


SAS is the leader in analytics. SAS helps customers at more than 83,000 sites make better decisions faster. In 2016, analysts named SAS a leader in predictive and advanced analytics, customer intelligence, data management, data integration and data quality. Maintaining this leadership is heavily dependent upon innovation. Year after year, SAS reinvests about twice the average of major technology firms into R&D – 26 percent in 2016. This unwavering commitment to innovation is behind the ground-breaking new SAS® Viya™ technology – dubbed by analysts as changing the industry. Since 1976, SAS has been giving customers around the world THE POWER TO KNOW®.

Silver Partner

ACI Clinical

ACI Clinical provides top-tier Endpoint Adjudication and Data Monitoring Committees that deliver reliable and trusted information in support of clinical development programs. As the only company focused entirely on expert committees, we understand every aspect of the process and what is truly needed to achieve the best results. Our Executives are involved in current regulatory efforts shaping committee practices and we continue to build our global network of more than 500 qualified experts to serve as a source of committee members. By leveraging these strong academic relationships with our proprietary technology and in-house expertise, ACI excels at designing and managing the entire committee process to meet any client’s needs.


Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.


Metronomia is an expert CRO for Biostatistics, Statistical consulting and Data management located in Munich, Germany. We offer high-quality clinical research services to pharmaceutical and biotech companies, along with the medical device industry. Since the foundation in 1990, Metronomia was successfully involved in more than 500 clinical projects, covering every clinical stage and project size throughout all major therapeutic areas.